obesity drug news today glp-1 october 21 2025 Rhode Island considers ending Medicaid coverage of GLP-1 drugs for weight loss • Rhode Island Current GLP-1 Weight-Loss Drug Demonstration Begins

While semaglutide targets a single receptor and tirzepatide targets two, retatrutide is a triple agonist simultaneously activating GLP-1, GIP, and glucagon receptors

Miranda-Daz AG, Pazarn-Villaseor L, Yanowsky-Escatell FG, Andrade-Sierra J

Physiological Aspects of Female Fertility: Role of the Environment, Modern Lifestyle, and Genetics

Metformin inhibits leptin secretion via a mitogen-activated protein kinase signalling pathway in Brown adipocytes

The same mechanisms contribute to a more resilient scalp environment, essential for healthy hair follicles

Inspired by the effects of microneedling, natural Dermal Micro-points innovative collagen-boosting gel formula mimics some of the benefits of the procedure, without the needles